NeoStem to Present Stem Cell Technology at OneMedForum NY 2011
NeoStem , an international biopharmaceutical company, will present at OneMedForum NY 2011.
news1
Cambridge Heart’s MTWA Test Featured As Case Of The Week In Diagnostic And Interventional Cardiology
Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, announced that its test was recently featured in Diagnostic and Interventional Cardiology as the Case of the Week.
Anavex Receives Approval to Commence Phase I Clinical Trial in Alzheimer’s Disease
Anavex Life Sciences recently announced that its clinical trial application for ANAVEX 2-73, the company’s lead compound for Alzheimer’s disease, has been approved by the German regulatory health authority.
1st Australian Total Artificial Heart Patient Bridged To Transplant
SynCardia Systems Inc, the Tucson-based manufacturer of the world’s only Total Artificial Heart, announced recently that St. Vincent’s Hospital in Sydney, Australia, has successfully bridged its first patient to transplant.
OSI Systems Receives FDA Clearance for New Device Used in Anesthesia Delivery
OSI Systems, Inc. announced that its Healthcare division, Spacelabs Healthcare, has received FDA 510k clearance for Enhanced Flow Meter Visualization.
Blood Test Shows Promise In Spotting SCID In Infants
UCSF doctors have developed a test that, using just a drop of blood taken within hours of a baby’s birth, can determine whether that child has a rare but potentially fatal immune deficiency disorder.
Photocure Develops a Non-surgical Treatment For HPV
A new non-surgical, tissue-preserving therapeutic procedure is being developed to more effectively remove HPV infection and treat precursors of cervical cancer.
OneMedForum NY 2011 Advisory Board Steering Committee Assembled
OneMedForum is pleased to announce the assembly of the OneMedForum NY 2011 Steering Committee.
Monica Healthcare Gains FDA Clearance For Groundbreaking Wireless Fetal Monitor
Monica Healthcare has announced that the US Food and Drug Administration (FDA) has granted regulatory clearance of their Monica AN24 wireless fetal monitor for use during Labor and Delivery.
NxThera Completes $12.6 Million in Series B Financing for Treating BPH
NxThera Inc., a St. Paul, Minn.-based privately held medical devices company, has added $12.6 million in Series B financing.